Drugs & Biologicals: Maximum Allowed Units (MAUs) – Palmetto GBA Medicare


CPT CODE description


J7030 – Infusion, normal saline solution , 1000 cc

Maximum Allowed Units List – 2

KEY

HCPCS Code
Code Description

MAU

Release Date

Reassesment

Date

J1956 Injection, levofloxacin, 250 mg 3 11/14/2008

J1980

Injection, hyoscyamine sulfate, up to 0.25 mg 6

12/16/2008

J2001 Injection, lidocaine HCl for intravenous infusion, 10 mg

210 12/16/2008

J2010

Injection, lincomycin HCl, up to 300 mg 7

12/3/2008

J2020 Injection, linezolid, 200

mg

3 7/17/2009
J2060 Injection, lorazepam, 2 mg

4 12/16/2008
J2150

Injection, mannitol, 25% in 50 ml 8

12/16/2008

7/1/2010
J2175 Injection, meperidine HCl, per 100 mg 3 12/3/2008

4 J2180

Injection, meperidine and promethazine HCl, up to 50

mg

0

11/21/2008

J2185 Injection, meropenem, 100 mg 88 12/16/2008

J2210

Injection, methylergonovine maleate, up to 0.2 mg 3

12/16/2008

7/1/2010
J2250 Injection, midazolam hydrochloride, per 1 mg 22 12/16/2008

J2270

Injection, morphine sulfate, up to 10 mg 3

11/14/2008

7/1/2010
J2271 Injection, morphine sulfate, 100 mg 1 11/14/2008

5 J2275

Injection, morphine sulfate (preservative-free sterile

solution), per 10 mg

15

12/3/2008

J2280 Injection, moxifloxacin, 100

mg

4 7/17/2009
J2300 Injection, nalbuphine HCl, per 10 mg

16 11/14/2008
J2310

Injection, naloxone hydrochloride, per 1 mg 10

12/16/2008

J2320 Injection, nandrolone deconoate, up to 50 mg 4 12/16/2008

J2321 Injection, nandrolone deconoate, up

to 100 mg

2 7/17/2009
J2322 Injection, nandrolone decanoate, up

to 200 mg

1 4/1/2010
J2323 Injection, natalizumab, 1 mg 300

11/14/2008
J2353

Injection, octreotide, depot form for intramuscular injection,

1 mg

30 12/16/2008

Denied
3

J2354 Injection, octreotide, non-depot form for subcutaneous or

intravenous injection, 25 mcg

0

12/16/2008
J2355 Injection, oprelvekin, 5 mg 1 11/14/2008

5

J2357 Injection, omalizumab, 5 mg

75

12/16/2008
J2360 Injection, orphenadrine citrate, up to 60 mg 1 12/3/2008

J2405 Injection, ondansetron hydrochloride, per 1 mg 50

12/16/2008
J2410

Injection, oxymorphone HCl, up to 1 mg

5 12/16/2008

J2430 Injection, pamidronate disodium, per 30 mg 3

11/14/2008
J2440

Injection, papaverine HCl, up to 60 mg

2 11/14/2008

J2460 Injection, oxytetracycline HCl, up

to 50 mg

5 7/17/2009
J2469 Injection, palonosetron HCl, 25 mcg 10 11/14/2008

J2503

Injection, pegaptanib sodium, 0.3 mg 2

11/14/2008

J2505 Injection, pegfilgrastim, 6 mg 1 11/7/2008

J2510

Injection, penicillin G procaine, aqueous, up to 600,000

units

4

11/14/2008

7/1/2010
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125

grams (1.125 grams)

12 12/16/2008 6/1/2010

J2550

Injection, promethazine HCl, up to 50 mg 3

12/3/2008

J2562 Injection, plerixafor, 1

mg

40 1/1/2010
J2597 Injection, desmopressin acetate, per 1 mcg

32 12/16/2008
4

J2650

Injection, prednisolone acetate, up to 1 ml 0

11/21/2008
3 J2675

Injection, progesterone, per 50 mg

0 11/21/2008

J2680 Injection, fluphenazine decanoate, up to 25 mg 4

11/14/2008
J2690

Injection, procainamide HCl, up to 1 gram

1 11/14/2008

J2720 Injection, protamine sulfate, per 10 mg 5

11/14/2008
J2760

Injection, phentolamine mesylate, up to 5 mg

1 11/14/2008

J2765 Injection, metoclopramide HCl, up to 10 mg 132

12/16/2008
J2778

Injection, ranibizumab, 0.1 mg

10 12/16/2008

J2780 Injection, ranitidine hydrochloride, 25 mg 4

12/16/2008
8 J2785

Injection, regadenoson, 0.1 mg

4 12/16/2008

J2788 Injection, RHo D immune globulin,

human, minidose, 50 micrograms

1 7/1/2010
J2790 Injection, RHo D immune globulin, human, full dose, 300

micrograms (1500 IU)

1 11/14/2008

J2791 Injection, RHo D immune globulin, human, IM or IV, 100

IU

275 7/1/2010
J2792

Injection, RHo D immune globulin, intravenous, human, solvent

detergent, 100 IU

300 11/14/2008

7/1/2010
5 J2793 Injection, rilonacept, 1

mg

440 1/1/2010
J2794 Injection, risperidone, long acting, 0.5 mg 100 11/14/2008

5 J2795

Injection, ropivacaine hydrochloride, 1 mg 300

12/16/2008

5 J2796 Injection, romiplostim, 10

micrograms

150 1/1/2010
J2800 Injection, methocarbamol, up to 10 ml

2 12/3/2008
J2805

Injection, sincalide, 5 micrograms 1

11/14/2008

 5

J2820 Injection, sargramostim (GM-CSF), 50 mcg

15 11/14/2008

2/17/2009

J2910

Injection, aurothioglucose, up to 50 mg 1

11/14/2008
4 J2912

Injection, sodium chloride, 0.9%, per 2 ml

0 11/14/2008

J2916 Injection, sodium ferric gluconate complex in sucrose

injection, 12.5 mg

10

12/16/2008
J2920

Injection, methylprednisolone sodium succinate, up to 40

mg

83 12/16/2008

J2930 Injection, methylprednisolone sodium succinate, up to 125

mg

27

12/16/2008
3 J2941

Injection, somatropin, 1 mg

0 11/21/2008

J2950 Injection, promazine HCl, up to 25 mg 8

12/16/2008
J2997

Injection, alteplase recombinant, 1 mg

100 12/16/2008

J3000 Injection, streptomycin, up to 1 gram 2

12/3/2008
5 J3010

Injection, fentanyl citrate, 0.1 mg

3 12/3/2008

3

J3030 Injection, sumatriptan succinate, 6 mg (only for direct

physician supervision administration)

0

11/21/2008
J3070 Injection, pentazocine, 30 mg 4 12/16/2008

1 J3100 Injection, tenecteplase, 50

mg

1 7/17/2009

8

J3101 Injection, tenecteplase, 1 mg

50 12/16/2008
J3105

Injection, terbutaline sulfate, up to 1 mg 1

11/14/2008

J3120 Injection, testosterone enanthate, up to 100 mg 4 12/3/2008

J3130

Injection, testosterone enanthate, up to 200 mg 2

11/14/2008

4

J3140 Injection, testosterone suspension, up to 50 mg

0 11/21/2008
4

J3150

Injection, testosterone propionate, up to 100 mg 0

11/21/2008
J3230

Injection, chlorpromazine HCl, up to 50 mg

4 12/16/2008

J3240 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg

vial

1

11/14/2008
J3243

Injection, tigecycline, 1 mg

100 11/14/2008

J3250 Injection, trimethobenzamide HCl, up to 200 mg 2

11/14/2008
J3260

Injection, tobramycin sulfate, up to 80 mg

5 12/16/2008

J3265 Injection, torsemide, 10 mg/ml 2

11/14/2008
8 J3300

Injection, triamcinolone acetonide, preservative free, 1

mg

40 12/16/2008

J3301 Injection, triamcinolone acetonide, not otherwise specified,

per 10 mg

16

12/16/2008
4 J3302

Injection, triamcinolone diacetate, per 5 mg

0 11/21/2008

J3303 Injection, triamcinolone hexacetonide, per 5 mg 12

12/16/2008 4/10/2009
J3315

Injection, triptorelin pamoate, 3.75 mg

6 11/14/2008

7/1/2010

J3360 Injection, diazepam, up to 5 mg

6

12/16/2008
J3370 Injection, vancomycin HCl, 500 mg 8 12/16/2008

9/18/2009

J3396 Injection, verteporfin, 0.1 mg

150

12/16/2008
J3410 Injection, hydroxyzine HCl, up to 25 mg 12 12/16/2008

J3411 Injection, thiamine HCl, 100 mg 1

11/21/2008
J3420

Injection, vitamin B-12 cyanocobalamin, up to 1000

mcg

1 11/21/2008

J3430 Injection, phytonadione (vitamin K), per 1 mg 100

12/16/2008
J3470

Injection, hyaluronidase, up to 150 units

2 11/21/2008

J3471 Injection hyaluronidase, ovine, preservative free, per 1 usp

unit (up to 999 USP units)

400

12/16/2008
J3473 Injection, hyaluronidase,

recombinant, 1 USP unit

300 7/17/2009
J3475

Injection, magnesium sulfate, per 500 mg 48

12/16/2008

J3480 Injection, potassium chloride, per 2 mEq 60 12/16/2008

J3486

Injection, ziprasidone mesylate, 10 mg 4

11/21/2008

J3487 Injection, zoledronic acid, 1 mg 4 12/3/2008

J3488

Injection, zoledronic acid, 1 mg 5

11/21/2008

2

J3520 Edetate disodium, per 150 mg

0 11/21/2008
2

J3535

Drug administered through a metered dose inhaler 0

11/21/2008
J7030

Infusion, normal saline solution, 1000 cc

2 12/16/2008

J7040 Infusion, normal saline solution, sterile (500 ml = 1

unit)

4

12/3/2008
J7042

5% dextrose/normal saline solution (500 ml = 1

unit)

4 12/3/2008

J7050 Infusion, normal saline solution , 250 cc 8

12/16/2008
J7060

5% dextrose/water (500 ml = 1 unit)

4 12/3/2008

J7070 Infusion, D5W, 1000 cc 2

11/21/2008
J7100 Infusion, dextran 40, 500

ml

2 7/1/2010
J7110 Infusion, dextran 75, 500

ml

2 7/1/2010
J7120

Ringers lactate infusion, up to 1000 cc 4

12/3/2008

7/1/2010

2

J7130 Hypertonic saline solution, 50 or 100 mEq, 20 cc

vial

0 11/21/2008
5 J7185 Injection, factor VII

(antihemophilic factor, recombinant) (Xyntha), per I.U.

5500  1/1/2010
8

J7186 Injection, antihemophilic factor VIII/Von Willebrand factor

complex (human), per factor VIII IU

5500

12/16/2008
5 J7192 Factor VIII (antihemophilic factor, recombinant) per

IU

5500 12/16/2008

2

J7300 Intrauterine copper contraceptive

0

11/21/2008
2 J7302 Levonorgestrel-releasing intrauterine contraceptive system, 52

mg

0 11/21/2008

J7308 Aminolevulinic acid HCl for topical administration, 20%,

single unit dosage form

2

11/21/2008
J7311

Fluocinolone acetonide, intravitreal implant

(Retisert)

1 11/21/2008

4/1/2010
2

J7317 Sodium hyaluronate, per 20 to 25 mg dose for intra-articular

injection

0

11/21/2008
J7321 Hyaluronan or derivative, Hyalgan or Supartz, for

intra-articular injection, per dose

2 11/21/2008

9

J7322 Hyaluronan or derivative, Synvisc, for intra-articular

injection, per dose

2

11/21/2008
J7323 Hyaluronan or derivative, Euflexxa, for intra-articular

injection, per dose

2 11/21/2008
J7324

Hyaluronan or derivative, Orthovisc, for intra-articular

injection, per dose

2

11/21/2008

J7325 Hyaluronan or derivative, Synvisc or Synvisc-One, for

intra-articular injection, 1 mg

96 1/1/2010
2 J7502 Cyclosporine, oral 100 mg 0 12/16/2008

2

J7506 Prednisone, oral, per 5 mg

0

12/16/2008
2 J7510 Prednisolone, oral, per 5 mg 0 12/16/2008

J7513 Daclizumab, parenteral, 25 mg 5

11/21/2008
2 J7515

Cyclosporine, oral, 25 mg

0 12/16/2008

7

J7602 Albuterol, all formulations including separated isomers,

inhalation, solution, FDA-approved final product, non-compounded, administered through DME,

concentrated form, per 1 mg (albuterol) or per 0.5 mg (levalbuterol)

3

12/16/2008
7 J7603 Albuterol, all formulations including separated isomers,

inhalation solution, FDA-approved final product, non-compounded, administered through DME,

unit dose, per 1 mg (albuterol) or per 0.5 mg (levalbuterol)

3 12/16/2008

8

J7606 Formoterol fumarate, inhalation solution, FDA-approved final

product, non-compounded, administered through DME, unit dose form, 20 micrograms

1

12/16/2008

J7607

Levalbuterol, inhalation solution, compounded product,

administered through DME, concentrated form, 0.5 mg

3

12/16/2008

J7615 Levalbuterol inhalation solution, compounded product,

administered through DME, unit dose, 0.5 mg

3 12/16/2008

J7620

Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg,

FDA-approved final product, non-compounded, administered through DME

1

12/16/2008

J7626 Budesonide, inhalation solution, FDA-approved final product,

non-compounded, administered trough DME, unit dose form, up to 0.5 mg

2 12/16/2008

4 J7628

Bitolterol mesylate, inhalation solution, compounded product,

administered through DME, concentrated form, per mg

0

11/21/2008

4

J7636 Atropine, inhalation solution, compounded product,

administered through DME, unit dose form, per mg

0 11/21/2008
J7638

Dexamethasone, inhalation solution, compounded product,

administered through DME,  unit dose form, per mg

10 12/16/2008
3 J7639 Dornase alpha, inhalation solution, FDA-approved final

product, non-compounded, administered through DME, unit dose form, per mg

0 12/16/2008
3

J7641

Flunisolide,  inhalation solution, compounded product,

administered through DME, unit dose, per milligram

0

12/16/2008
3 J7643

Glycopyrrolate, inhalation solution, compounded product,

administered through DME, unit dose, per mg

0 12/16/2008

J7644 Ipratropium bromide, inhalation solution, FDA-aapproved final

product, non-compounded, administered through DME, unit dose form, per mg

1

12/16/2008
J7645

Ipratropium bromide, inhalation solution, compounded product,

administered through DME, unit dose, per mg

1 12/16/2008

J7668 Metaproterenol sulfate, inhalation solution, FDA-approved

final product, non-compounded, administesred through DME, concentrated form, per

10mg

2

12/16/2008
J7681

Terbutaline sulfate, inhalant solution, compounded product,

administered through DME, unit dose form, per mg

3 12/16/2008

3

J7685 Tobramycin, inhalation solution, compounded product,

administered through DME, unit dose form, per 300mg

0

12/16/2008
2 J8501 Aprepitant, oral, 5 mg 0 11/21/2008

2

J8521 Capecitabine, oral, 500 mg

0

12/16/2008
2 J8530 Cyclophosphamide, oral, 25 mg 0 12/16/2008

2

J8600 Melphalan, oral, 2mg

0

12/16/2008
2 J8700 Temozolmide, oral 5 mg 0 11/21/2008

2, 8

J8705 Topotecan, oral, 0.25 mg

0

12/16/2008
J9000 Injection, doxorubicin hydrochoride, 10 mg 18 12/16/2008

J9001 Injection, doxorubicin hydrochloride, all lipid formulations,

10 mg

14

11/7/2008 7/1/2010
J9010

Injection, alemtuzumab, 10 mg

3 11/7/2008

J9015 Aldesleukin, per single use vial 6

12/16/2008
J9017

Injection, arsenic trioxide, 1 mg

20 12/3/2008

1/12/2009

J9020 Injection, asparaginase, 10,000 units

2

11/21/2008
J9025 Injection, azacitidine, 1 mg 300 12/3/2008

J9031 BCG (intravesical), per instillation 1

11/21/2008
8 J9033

Injection, bendamustine HCl, 1 mg

300 12/16/2008

J9035 Injection, bevacizumab, 10 mg 170

12/3/2008 Denied
J9040

Injection, bleomycin sulfate, 15 units

4 11/21/2008

J9041 Injection, bortezomib, 0.1 mg 35

11/7/2008
J9045

Injection, carboplatin, 50 mg

20 11/21/2008

Denied

J9050 Injection, carmustine, 100 mg

5

12/3/2008
J9055 Injection, cetuximab, 10 mg 120 11/7/2008

2/27/2009 

J9060 Cisplatin, powder or solution, per 10 mg

24

12/3/2008
J9062 Cisplatin, 50 mg 5 11/21/2008

J9065 Injection, cladribine, per 1 mg 11

11/21/2008 6/1/2010
J9070

Cyclophosphamide, 100 mg

55 12/3/2008

J9080 Cyclophosphamide, 200 mg 19

12/16/2008 7/1/2010
J9090

Cyclophosphamide, 500 mg

11 12/3/2008

J9091 Cyclophosphamide, 1.0 gram 

6

12/3/2008
J9092 Cyclophosphamide, 2.0 gram   3

11/21/2008

J9093 Cyclophosphamide, lyophilized, 100 mg  

24 12/3/2008

7/1/2010

J9094

Cyclophosphamide, lyophilized, 200 mg 19

12/16/2008 7/1/2010
J9095

Cyclophosphamide, lyophilized, 500 mg   

6 12/3/2008

7/1/2010

J9096 Cyclophosphamide, lyophilized, 1.0 gram  

4 12/3/2008 7/1/2010

J9097

Cyclophosphamide, lyophilized, 2.0 gram  

2 11/21/2008 7/1/2010
J9098 Injection, cytarabine liposome, 10 mg

5 11/21/2008
J9100

Injection, cytarabine, 100 mg 3

11/21/2008

J9110 Injection, cytarabine, 500 mg 10 11/21/2008 3/12/2009

J9120

Injection, dactinomycin, 0.5 mg 4

11/21/2008

J9130 Dacarbazine, 100 mg 10 12/3/2008 6/12/2009

J9140

Dacarbazine, 200 mg 5

12/3/2008

2/27/2009 
J9150 Injection, daunorubicin, 10 mg 11 12/3/2008

J9155 Injection, degarelix, 1

mg

240 1/1/2010

J9160

Injection, denileukin diftitox, 300 micrograms 7

11/21/2008
9 J9170

Injection, docetaxel, 20 mg

12 11/21/2008

J9171 Injection, docetaxel, 1

mg

240 1/1/2010 1/8/2010

J9178

Injection, epirubicin HCl, 2 mg 150

12/16/2008
J9181

Injection, etoposide, 10 mg

30 12/3/2008

6/23/2009

J9182 Etoposide, 100 mg

3

11/21/2008
J9185 Injection, fludarabine phosphate, 50 mg 2 11/21/2008

J9190 Injection, fluorouracil, 500 mg 21

11/21/2008 1/12/2009
J9200

Floxuridine, 500 mg

4 12/16/2008

J9201 Injection, gemcitabine hydrochloride, 200 mg 14

11/7/2008
J9202

Goserelin acetate implant, per 3.6 mg

3 11/7/2008

J9206 Injection, irinotecan, 20 mg 42

11/7/2008
8 J9207

Injection, ixabepilone, 1 mg

105 12/16/2008

J9208 Injection, ifosfamide, 1 gram 6

12/3/2008 2/27/2009
J9209

Injection, mesna, 200 mg

30 12/3/2008

2/27/2009 

J9211 Injection, idarubicin hydrochloride, 5 mg

8

12/16/2008
J9213 Injection, interferon, alfa-2A, recombinant, 3 million units

3 11/21/2008

J9214 Injection, interferon, alfa-2B, recombinant, 1 million

units

100

11/21/2008
3 J9216

Injection, interferon, gamma 1-B, 3 million units

0 11/21/2008

J9217 Leuprolide acetate (for depot suspension), 7.5 mg 6

12/16/2008 4/24/2009
J9218 Leuprolide acetate, per 1 mg 1 7/1/2010

J9219

Leuprolide acetate implant, 65 mg 1

12/16/2008
J9225

Histrelin implant, 50 mg

1 12/16/2008

J9226 Histrelin implant, 50 mg 1

12/16/2008
J9230

Mechlorethamine HCl, (nitrogen mustard), 10 mg

5 12/16/2008

J9245 Injection, melphalan HCl, 50 mg 1

11/21/2008
J9250

Methotrexate sodium, 5 mg

7200 12/16/2008

J9260 Methotrexate sodium, 50 mg 720

12/16/2008
J9263

Injection, oxaliplatin, 0.5 mg

624 12/16/2008

2/27/2009 

J9264 Injection, paclitaxel protein-bound particles, 1 mg

624

12/16/2008
J9265 Paclitaxel, 30 mg 18 12/16/2008

2/27/2009

J9268 Injection, pentostatin, per 10 mg

1

11/21/2008
J9280 Mitomycin, 5 mg 10 12/16/2008

J9290 Mitomycin, 20 mg 3

11/21/2008
J9291

Mitomycin, 40 mg

2 11/21/2008

J9293 Injection, mitoxantrone hydrochloride, per 5 mg 10

12/16/2008
J9300

Injection, gemtuzumab ozogamicin, 5 mg

5 12/3/2008

J9303 Injection, panitumumab, 10 mg 70

12/16/2008 4/20/2010
J9305

Injection, pemetrexed, 10 mg

120 12/3/2008

J9310 Injection, rituximab, 100 mg 11

11/7/2008
J9320

Injection, streptozocin, 1 gram

4 12/16/2008

J9328 Injection, temozolomide, 1

mg

500 1/1/2010

8

J9330 Injection, temsirolimus, 1 mg

25 12/16/2008
J9340

Injection, thiotepa, 15 mg 6

12/3/2008

J9350 Injection, topotecan, 4 mg 10 12/3/2008 1/12/2009

J9355

Injection, trastuzumab, 10 mg 88

11/7/2008

Denied
J9360 Vinblastine sulfate, 1 mg 45 12/16/2008

J9370

Vincristine sulfate, 1 mg 4

12/16/2008

J9375 Vincristine sulfate, 2 mg 2 12/3/2008

J9380 Vincristine sulfate, 5

mg

1 4/1/2010

J9390

Injection, vinorelbine tartrate, per 10 mg 8

12/3/2008
J9395

Injection, fulvestrant, 25 mg

20 11/21/2008

6/1/2010
Q0138 Injection ferumoxytol, for treatment

of iron deficiency anemia, 1 mg (non-ESRD use)

510 1/1/2010
Q0139 Injection ferumoxytol, for treatment

of iron deficiency anemia, 1 mg (for ESRD use)

510 1/1/2010
9 Q2024 Injection, bevacizumab, 0.25

mg 

510 10/1/2009 
6 Q4083

Hyalgan-supartz, per dose 2

11/21/2008

6

Q4084 Synvisc, per dose

2 11/21/2008
6

Q4085

Euflexxa, per dose 2

11/21/2008
6 Q4086

Orthovisc, per dose

2 11/21/2008

GENERAL INFORMATION




Effective April 1, 2002, CWF edits were implemented to identify HCPCS codes for ambulance services that are either subject to or excluded from Skilled Nursing Facility (SNF) consolidated billing (CB). This coding change added SNF CB edits to CWF to deny payment of some separately billed ambulance services for beneficiaries in a SNF Part A covered stay. Effective July 1, 2003, CWF added an edit to allow claims submitted with specialty type “59” and HCPCS codes J7030 or J7050 (Saline Solution Injection) to process and pay correctly for modifiers other than “NN” when a beneficiary is in a Part A stay, and for claims submitted with an “NN” modifier when the beneficiary is not in a Part A stay. Since the implementation of this update, CMS has identified additional HCPCS codes for drugs and CPT codes for electrocardiogram (EKG) testing that may be separately payable when provided during a SNF ambulance transport that is not subject to SNF CB. HCPCS J-codes (J0000-J9999) not included in previous updates, Q-codes for anti-emetic drugs (Q0163 through Q0181), and CPT codes for EKG testing (93005 and 93041) will be added to the CWF SNF CB bypass for ambulance specialty type “59” carrier claims during the October 2004 SNF CB quarterly update.

Hydration (90760–90761)

Hydration codes are used for reporting intravenous (IV) administration of prepackaged fluid and electrolytes. These codes are not applicable to infusion of drugs or other substances and should not be reported if concurrently administered with chemotherapy or infusions of other drugs. Hydration is typically not a high-risk procedure, and once the IV line is in place, the patient requires little monitoring. Documentation of start and stop times is needed to allow the coder to choose the correct code(s). The codes are based on time, with 90760 for the initial hour and an add-on code of 90761 used for each additional hour.

Supply codes (substance/drug and amount administered) for injections and infusions are documented using a “J” code from HCPCS Level II, such as J7030 for infusion of normal saline solution, 1,000 mL. Some commercial payers do not accept the HCPCS Level II supply codes and will not reimburse for them. In this case, CPT provides a general supply code, 99070, that is submitted along with the name(s) of the product(s) used. To avoid repeating the code for a particular product (e.g., drug), the number of units can be reported in an additional field on the billing form/abstract.

A dehydrated patient is infused with one unit of a 5% dextrose/normal saline solution, which takes approximately 50 minutes: 90760, J7042. Alternatively, supply code 99070 can be used for the product administered if required by the payer (in place of J7042).

CPT provides codes for intravenous push and intra-arterial push. A substance that is pushed is injected directly into an existing IV line that is in use. To use these push codes, the provider must be present for the administration of the substance, or the infusion must take less than 16 minutes to complete. If a push is given subsequent to starting a separate infusion, then the push is coded as subsequent, not as an initial service. If a total infusion lasts less than 16 minutes, the push code is assigned for the service. Push codes cannot be assigned for infusion services that do not meet the time
requirements for add-on codes. For instance, if a patient receives an (initial) infusion for 1 hour 10 minutes, only the initial code of 90765 would be assigned. No add-on or push code can be assigned for the 10 minutes past 1 hour of services.

EXAMPLE Patient presents with severe vomiting and dehydration. IV infusion of normal saline,  1,000 mL for 2 hours. Phenergan IV push given. Report code 90774 for IV push, 90761, 90761 for administration of hydration (normal saline), and the following “J” codes from HCPCS Level II for the products administered: J2550, J7030. (Some payers do not recognize “J” codes, and then the supply code 99070 can be used for the products administered.)